<DOC>
	<DOCNO>NCT01708265</DOCNO>
	<brief_summary>The purpose study compare early mitral valve repair versus watchful wait strategy asymptomatic patient severe organic mitral valve regurgitation preserve leave ventricular function .</brief_summary>
	<brief_title>The Dutch Asymptomatic Mitral Regurgitation Trial</brief_title>
	<detailed_description>Severe asymptomatic organic mitral valve ( MV ) regurgitation preserve left ventricular ( LV ) function challenge clinical entity data recommend treatment strategy patient scarce conflicting , reflect current guideline . European guideline advocate conservative strategy i.e . watchful waiting , yearly echocardiography , whilst American guideline favour early surgery reconstruct MV , i.e . MV repair ( contrast MV replacement ) order prevent future LV dysfunction complaint . A number non-randomised trial show favourable outcome early surgery early surgery strategy show associate improved long-term survival , decrease cardiac mortality decrease morbidity compare conservative management [ citation 1-3 ] . On hand , non-randomised trial describe also conservative strategy ( i.e . watchful wait ) safely accomplish . If facilitate surgery perform population proven eventually associate good perioperative postoperative outcome 50 % patient 10 year careful follow-up carry [ citation 4 ] . Non-randomised trial inherently number drawback . A randomised trial compare strategy objectivising best treatment strategy never perform . The Dutch AMR ( Asymptomatic Mitral Regurgitation ) trial multicenter , prospective , randomised trial compare early MV repair versus watchful wait asymptomatic patient severe organic MV regurgitation preserve LV function [ citation 5 , 6 ] .</detailed_description>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<criteria>Asymptomatic Severe organic mitral valve regurgitation . Preserved leave ventricular function ( left ventricular ejection fraction &gt; 60 % leave ventricular endsystolic dimension â‰¤45 mm ) The likelihood MV repair 90 % determine local heart team cardiologist cardiothoracic surgeon Pulmonary hypertension ( &gt; 50 mmHg rest ) Atrial fibrillation Physical inability determine heart team undergo surgery Other lifethreatening morbidity Higher expect surgical risk advance , accord dedicate heart team Moderate severe kidney disease ( eGFR less 30 mL/min ) Flail leaflet together leave ventricular end systolic diameter ( LVESD ) &gt; 40 mm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Mitral Valve Insufficiency</keyword>
	<keyword>Mitral Valve Regurgitation</keyword>
	<keyword>Asymptomatic Mitral Valve Regurgitation</keyword>
	<keyword>Asymptomatic Mitral Valve Insufficiency</keyword>
	<keyword>Mitral Valve Repair</keyword>
	<keyword>Watchful Waiting</keyword>
</DOC>